arrow
C

Christine Gennigens

department of medical oncology, chu of liège, avenue de l’hôpital 1, 4000 liège, belgium
H指数:8
被引数:363

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201

阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌:ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结

2025-12-120
OAAI
A plain language summary publication of patients’ survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel

一份关于接受多塔利单抗联合卡铂-紫杉醇治疗子宫内膜癌患者生存情况的通俗语言摘要出版物

2025-10-090
OA
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
2024-11-080
OAAI
Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel- paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial
2024-08-014
OA